D-19 | Acute Myocardial Infarction-related Cardiogenic Shock Survivorship: A Pilot Study in Quality of Life

Very little is understood about the quality of life (QoL) of cardiogenic shock survivors after acute myocardial infarction (AMI-CS). This pilot study describes the short-term QoL of AMI-CS patients following discharge. This single-center prospective pilot study included adult patients with SCAI Stage B or C AMI-CS who underwent revascularization of culprit lesions. All patients for whom the catheterization lab was activated were reviewed. Those patients exhibiting clinical and/or hemodynamic criteria of shock were included. Patients with mixed shock, acute-on-chronic decompensated heart failure, catheterization-related complications, undergoing or post-heart transplant, discharged on durable mechanical circulatory support, or dementia were excluded. The EuroQol-5D survey was administered via telephone 7- and 30-days post-discharge. Ten patients were included. Nearly all patients required either vasopressor/inotrope (n=9, 90%) or mechanical circulatory support (n=8, 80%) via intra-aortic balloon pump. Mean (SD) hospitalization was 6.6 (6.8) days, and patients averaged 5.8 (2.4) new medications at discharge. Patients reported minimal QoL concerns across five dimensions at both 7 and 30 days after discharge (Figure 1) and self-scored their overall health at 72.5/100 and 69.4/100 at days 7 and 30, respectively. Following survival from AMI-CS, self-reported QoL was largely preserved the first month after discharge. These data inform future studies evaluating therapies for AMI-CS that aim to improve both mortality and QoL among AMI-CS patients.